Adherence to national recommendations for the control of multidrug-resistant microorganisms in Swiss acute care hospitals – an updated national survey
Andrea Büchler(Swiss National Science Foundation), Hugo Sax(University of Bern), Danielle Vuichard‐Gysin, Matthias Schlegel, Carlo Balmelli, Aliki Metsini(Swiss National Science Foundation), Simon Gottwalt(Federal Office of Public Health), Aline Wolfensberger(University of Zurich), Sarah Tschudin‐Sutter(University of Basel), Andreas F. Widmer(University of Basel), Gaud Catho(University of Geneva), Niccolò Buetti(University of Geneva), Philipp Jent(University of Bern), Laurence Senn(University of Lausanne), Stéphan Harbarth(World Health Organization)
Cited by 1
Related Papers
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
|Clinical Microbiology and Infection|2021|615
Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): An international survey
|Journal of Critical Care|2020|350
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008
|Eurosurveillance|2008|286
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study
|Intensive Care Medicine|2023|257
Livestock-associated Methicillin-Resistant<i>Staphylococcus aureu</i>s in Humans, Europe
|Emerging infectious diseases|2011|210